文献速递头颈甲状腺与浅表CT

基于双能CT的甲状腺乳头状癌患者侧颈淋巴结转移新预测模型

A new prediction model for lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma: Based on dual-energy CT.
PubMed 文献 · Eur J Radiol · 2021-11-22

回顾性纳入406例(2015年7月至2019年6月)构建并内部验证、101例(2019年7月至2020年6月)外部验证基于双能CT的甲状腺乳头状癌侧颈淋巴结转移预测模型。动脉期碘浓度、静脉期碘浓度、位于上极及甲状腺外侵犯为独立危险因素,列线图在推导、内部及外部验证队列AUC分别为0.899、0.905、0.912,决策曲线显示使用列线图可增加获益,提示推荐行侧颈淋巴结清扫。

要点

  • 动脉期碘浓度、静脉期碘浓度、位于上极及甲状腺外侵犯是侧颈淋巴结转移的独立危险因素。
  • 基于上述4个预测因子的列线图在推导、内部及外部验证队列AUC分别为0.899、0.905、0.912。
  • 决策曲线显示使用列线图估计侧颈淋巴结转移可增加获益,提示推荐行侧颈淋巴结清扫。

核心结论

  • 双能CT参数可提供甲状腺乳头状癌患者侧颈淋巴结转移的独立指标,基于其构建的列线图可能有助于治疗决策。

研究设计与样本

  • 回顾性研究,推导队列为2015年7月至2019年6月连续406例患者并行内部验证,外部验证队列为2019年7月至2020年6月连续101例患者,采用单因素和多因素logistic回归分析独立危险因素并构建基于双能CT参数的列线图预测模型。

诊断标准与关键数值

  • 动脉期碘浓度(OR 2.761,95%CI 1.028-7.415,P 0.044)、静脉期碘浓度(OR 3.820,95%CI 1.430-10.209,P 0.008)、位于上极(OR 4.181,95%CI 2.645-6.609,P 0.000)及甲状腺外侵犯(OR 4.392,95%CI 2.142-9.004,P 0.000)为侧颈淋巴结转移的独立危险因素,纳入列线图;模型区分度在推导队列AUC 0.899、内部验证AUC 0.905、外部验证AUC 0.912。

临床应用与阅片要点

  • 原文结论指出双能CT参数可提供侧颈淋巴结转移的独立指标,基于其构建的列线图可能有助于治疗决策;决策曲线显示使用列线图估计侧颈淋巴结转移可增加获益,提示推荐行侧颈淋巴结清扫。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The current study aimed to develop and validate a prediction model to estimate the independent risk factors for lateral cervical lymph node metastasis (LLNM) in papillary thyroid carcinoma (PTC) patients based on dual-energy computed tomography (DECT).

METHOD: This study retrospectively conducted 406 consecutive patients from July 2015 to June 2019 to form the derivation cohorts and performed internal validation. 101 consecutive patients from July 2019 to June 2020 were included to create the external validation cohort. Univariable and multivariable logistic regression analyses were used to evaluate independent risk factors for LLNM. A prediction model based on DECT parameters was built and presented on a nomogram. The internal and external validations were performed.

RESULTS: Iodine concentration (IC) in the arterial phase (OR 2.761, 95% CI 1.028-7.415, P 0.044), IC in venous phase (OR 3.820, 95% CI 1.430-10.209, P 0.008), located in the superior pole (OR 4.181, 95% CI 2.645-6.609, P 0.000), and extrathyroidal extension (OR 4.392, 95% CI 2.142-9.004, P 0.000) were independently associated with LLNM in the derivation cohort. These four predictors were incorporated into the nomogram. The model showed good discrimination in the derivation (AUC, 0.899), internal (AUC, 0.905), and external validation (AUC, 0.912) cohorts. The decision curve revealed that more advantages would be added using the nomogram to estimate LLNM, which implied that the lateral lymph node dissection was recommended.

CONCLUSIONS: DECT parameters could provide independent indicators of LLNM in PTC patients, and the nomogram based on them may be helpful in treatment decision-making.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zou, Sun, Liu, et al. A new prediction model for lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma: Based on dual-energy CT. Eur J Radiol. 2021. PMID: 34839216. doi:10.1016/j.ejrad.2021.110060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。